Somatostatin analogs: does pharmacology impact antitumor efficacy?
about
The somatostatin analog 188Re-P2045 inhibits the growth of AR42J pancreatic tumor xenograftsPharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors.Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series.Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis.Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitroPituicytoma-An outlook on possible targeted therapies.Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.Progress in the formulation and delivery of somatostatin analogs for acromegaly.
P2860
Q35534233-5EAEBC4A-AAE4-43B6-BE7B-6D42FA3EFB87Q35695360-078D4603-5303-46F3-B471-B998647BD4CFQ36568335-7B3C6F92-E88D-48D8-B469-47A2271C1DF8Q36588574-C6472B10-A7F9-4817-B98C-C58A0F614363Q38538085-E5C3E151-1A3C-4CD6-9F8E-DD1D1C36A15FQ40661336-DE154246-78EB-422A-AED9-AA77DC2835F3Q41548629-9EFE4582-35FB-47C0-A278-5BA408F9D7F9Q47748900-1AE4F2EB-B8D4-4ACA-AE86-7DC96CBBCF37Q47805050-C8137C2B-4422-4968-90CF-31D156306666Q47928226-D002564F-CEA3-480A-842F-FC25F11EEA12
P2860
Somatostatin analogs: does pharmacology impact antitumor efficacy?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Somatostatin analogs: does pharmacology impact antitumor efficacy?
@en
type
label
Somatostatin analogs: does pharmacology impact antitumor efficacy?
@en
prefLabel
Somatostatin analogs: does pharmacology impact antitumor efficacy?
@en
P2093
P1476
Somatostatin analogs: does pharmacology impact antitumor efficacy?
@en
P2093
Camille Duluc
Corinne Bousquet
Delphine Vezzosi
Mounira Chalabi
Philippe Caron
Stéphane Pyronnet
P304
P356
10.1016/J.TEM.2013.11.003
P577
2014-01-07T00:00:00Z